Skip to main content

Table 1 Clinical manifestations of patients with intestinal BS and mucocutaneous BS

From: Clinical characteristics and risk factors of intestinal involvement in Behçet’s syndrome patients: a cross-sectional study from a single center

Variables

Intestinal BS (n, %)

Mucocutaneous BS (n, %)

Clinical manifestations of disease first onset

  

Fever

17 (17.53)

9 (5.84)

Oral ulcers

97 (100.00)

154 (100.00)

Genital ulcers

61 (62.89)

135 (87.66)

Erythema nodule

28 (28.87)

73 (47.40)

Pseudofolliculitis

25 (25.77)

39 (25.32)

Ocular involvement

5 (5.15)

0 (0.00)

Arthritis or Arthralgia

16 (16.49)

21 (13.64)

Vascular involvement

2 (2.06)

0 (0.00)

Gastrointestinal lesions

28 (28.87)

0 (0.00)

Hematologic involvement

2 (2.06)

0 (0.00)

Clinical manifestations during hospitalization

  

Headache

1 (1.03)

0 (0.00)

Oral ulcers

47 (48.45)

98 (63.64)

Genital ulcers

16 (16.49)

34 (22.08)

Erythema nodule

14 (14.43)

41 (26.62)

Skin pustules

0 (0.00)

2 (1.30)

Arthralgia

7 (7.22)

0 (0)

Arthritis

2 (2.06)

0 (0)

Nausea/vomiting/abdominal pain

49 (50.52)

0 (0.00)

Diarrhea/hematochezia

23 (23.71)

0 (0.00)

Ocular involvement

3 (3.09)

0 (0.00)

Nervous system involvement

1 (1.03)

0 (0.00)

Major vessel involvement

2 (2.06)

0 (0.00)

Hematologic involvement

6 (6.19)

0 (0.00)

Surgical treatment of bowel resection

13 (13.40)